A bellwether trial over the risk of bleeding injury with Xarelto (rivaroxoaban) opened in Philadelphia in early November. The trial will hear a case filed by Lynn Hartman and her spouse, alleging that Xarelto’s side effects cause Ms. Hartman to experience severe internal bleeding. Xarelto... Read More

A class action suit against DePuy International Ltd.’s Pinnacle Ultamet hip replacement was filed in mid-October in the United Kingdom. The suit, with more than 300 claimants, is one of the largest ever brought against a company there. DuPuy is a subsidiary of United States-based... Read More

Johnson & Johnson officials knew that the talc used to make its products contained asbestos in the 1970s, according to documents recently unsealed as part of a court case against the drug manufacturer. The case alleges that the talc caused ovarian cancer in women who... Read More

In mid September, a North Carolina woman’s lawsuit became the latest claim added to those in multidistrict legislation (MDL) alleging that Bayer Healthcare’s Mirena IUD caused pseudotumor cerebri (PTC). Like others in the MDL, the Mirena IUD lawsuit, brought by Tabitha Lee, charges the drug... Read More

A wrongful death lawsuit was filed in mid September by the family of a Tennessee woman who was prescribed Farxiga for type 2 diabetes, alleging that side effects of the diabetes medication caused the kidney failure that killed her. Farxiga Side Effects Said to Cause... Read More

Less than six months after rejecting a request to centralize the management of cases against the manufacturers of Nexium and other proton pump inhibitors (PPIs), the U.S. Judicial Panel on Multidistrict Litigation (JPML) in early August moved to coordinate the cases before Claire C. Cecchi,... Read More

The maker of testosterone enhancer AndroGel is legally liable for concealing the risk of heart attack, according to the results of a recent case. Abbvie Inc. was ordered to pay $150 million in punitive damages because it did not represent AndroGel’s safety profile accurately to... Read More

Patients who used Nexium and other proton pump inhibitors (PPIs) for heartburn via prescription ran a higher risk of dying than patients prescribed other drugs, a recent study indicates. Researchers in BMJ Open, a medical journal, compared the outcomes of patients who took Nexium and... Read More